
Chari A, Larson S, Holkova B, et al. Phase 1 trial of ibrutinib
Advertisement
Articles by Chari A, Larson S, Holkova B, et al. Phase 1 trial of ibrutinib

Advertisement
Latest Updated Articles
Study Summary: Ibrutinib Plus Carfilzomib for Relapsed or Relapsed/Refractory Multiple MyelomaPublished: October 18th 2018 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
TrumpRx Launch Brings Savings—and Uncertainty
2
How Do GLP-1 Agonists Fit Into Stroke Care?
3
Addressing Disparities at Every Step of the Stroke Care Pathway: Luke Messac, MD, PhD
4
Understanding Real-World MRI Utilization for ED Dizziness: Ava L. Liberman, MD
5



